Innovation

Munc18-1 and -2 double knockdown PC12 cells

University Health Network - Technology Development and Commercialization
posted on 03/12/2012

Available for licensing: Munc 18-1 and Munc 18-2 double knockdown PC12 cells.


Innovation Details
 

Detailed Description

"Munc18-1 binds to syntaxin-1A via two distinct sites referred to as the ‘closed’ conformation and Nterminus binding. The latter has been shown to stimulate SNARE-mediated exocytosis, whereas the former is believed to be inhibitory or dispensable. To precisely define the contributions of each binding mode, we have engineered Munc18-1/-2 double knockdown neurosecretory cells and show that not only syntaxin-1A and -1B but also syntaxin-2 and -3 were significantly reduced as a result of Munc18-1 and - 2 knockdown."

File Number: MD-PC12 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Yuan Lew at University Health Network - Technology Development and Commercialization for more information.

Request more info via email request more info
People

Case Manager:

Yuan Lew Yuan Lew

Innovations (39)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

12,924 members 17,197 innovations 176 organizations

Browse

William Garner, M.D., MPH - CEO of Urigen, N.A., Inc.

"The iBridge Network provides an important additional pathway for entrepreneurs to access university innovations that may otherwise have been lost. The transparency of this pathway between entrepreneurs..."  read more...